Intensive Care Medicine

, Volume 31, Issue 2, pp 315–316

Recombinant FVII in orthotopic liver transplantation (OLT): a preliminary single centre experience

  • Andrea De Gasperi
  • Francesco Baudo
  • Luciano De Carlis
Correspondence

References

  1. 1.
    Key NS (2003) Recombinant Factor VIIa for intractable hemorrhage: more questions than answers. Transfusion 43:1649–1651PubMedGoogle Scholar
  2. 2.
    Kang YG (2000) Coagulopathy in hepatic disease. Liver Transpl 6:S72–75PubMedGoogle Scholar
  3. 3.
    Porte RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L, Palareti G, Hermans J, Terpstra OT (2000) Aprotinin for reducing blood loss and transfusion requirements in orthotopic liver transplantation: a multicentre, randomised, double-blind study. Lancet 355:1303CrossRefPubMedGoogle Scholar
  4. 4.
    Hendriks HGD, Mejer K, De Wolf JT, Klompaker IJ, Porte RJ, de Kam PJ, Hagenaars AJ, Melsen T, Sloof MJ, van der Meer J (2001) Reduced transfusion requirements by recombinant Factor VIIa in orthotopic liver transplantation. Transplantation 71:402–405CrossRefPubMedGoogle Scholar
  5. 5.
    Plasinich R, Testa G, Sucru Emre, Grande L, Candela, A, van der Meer JV, Porte R, Ghobrial RM, Isoniemi H, Schelde P, Erhardsen E, Klimtmalm G (2002) Safety and efficacy of single bolus dose of recombinant factor VIIa in patients undergoing orthotopic liver transplantation: a randomized multicenter trial (abstract). Hepatology 36:660CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Andrea De Gasperi
    • 1
  • Francesco Baudo
    • 2
  • Luciano De Carlis
    • 3
  1. 1.2° Servizio Anestesia, Rianimazione e Trapianti AddominaliOspedale Niguarda Ca GrandaMilanItaly
  2. 2.Ematologia, Struttura Semplice di Trombosi ed Emostasi Ospedale Niguarda Ca GrandaMilanItaly
  3. 3.Chirurgia Generale e dei Trapianti AddominaliOspedale Niguarda Ca GrandaMilanItaly

Personalised recommendations